Dystrophy of Oligodendrocytes and Adjacent Microglia in Prefrontal Gray Matter in Schizophrenia

Natalya A Uranova1, Olga V Vikhreva1, Valentina I Rakhmanova1

  • 1Laboratory of Clinical Neuropathology, Mental Health Research Center, Moscow, Russia.

Abstract

Insights

Microglial activation and dystrophy may damage oligodendrocytes in schizophrenia, particularly in patients with positive symptoms. Targeting mitochondrial health in both cell types could be a key treatment strategy.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Psychiatry

Background:

  • Microglia activation is implicated in schizophrenia, potentially damaging oligodendrocytes and white matter.
  • Previous research noted oligodendrocyte dystrophy in the prefrontal white matter of schizophrenia subjects with positive symptoms.
  • This study investigated the link between microglial activation and oligodendrocyte dystrophy in the prefrontal gray matter of schizophrenia patients.

Purpose of the Study:

  • To examine the role of microglial activation in oligodendrocyte dystrophy in schizophrenia.
  • To compare microglia and oligodendrocyte morphology in schizophrenia subtypes (positive and negative symptoms) versus controls.
  • To identify potential cellular targets for schizophrenia treatment.

Main Methods:

  • Transmission electron microscopy and morphometry were used.
  • Microglia and adjacent oligodendrocytes were analyzed in layer 5 of the prefrontal cortex (BA10).
  • Subjects included schizophrenia with predominantly positive symptoms (SPPS, n=12), negative symptoms (SPNS, n=9), and healthy controls (n=20).

Main Results:

  • Activated microglia and dystrophic oligodendrocytes were observed adjacent to each other in both SPPS and SPNS groups compared to controls.
  • Both cell types showed reduced mitochondrial volume density and number, and increased lipofuscin granules.
  • SPPS group exhibited increased lipofuscin granules, and endoplasmic reticulum vacuoles in microglia, with correlations between mitochondrial and vacuole parameters.

Conclusions:

  • Microglial dystrophy may contribute to oligodendrocyte dystrophy in schizophrenia patients with positive symptoms during relapse.
  • Mitochondria in both microglia and oligodendrocytes are potential therapeutic targets for schizophrenia treatment.

Related Concept Videos

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.7K
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
405
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
393
Schizophrenia01:17

Schizophrenia

Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
616